J Cell Physiol. 2003 Aug;196(2):207-18. Dolcetti R, Masucci MG. Immunovirology and Biotherapy Unit, Department of Pre-Clinical and Epidemiological Research, C.R.O.-I.R.C.C.S., National Cancer Institute, Aviano (PN), Italy.
Subscribe to the World's Most Popular Newsletter (it's free!)
Epstein-Barr virus (EBV), a ubiquitous human herpes virus, is associated with an increasing number of lymphoid and epithelial malignancies. The ability of the virus to establish life-long persistent infections and induce growth transformation is related to the function of a set of viral proteins that are variously expressed in both normal and malignant cells. Recent evidence indicates that these viral proteins are able to usurp cellular pathways that promote the cell growth and survival, while impairing anti-viral immune responses. Elucidation of the mechanisms by which EBV induces cell transformation and escapes host immune control provides the rational background for the design of new strategies of intervention for EBV-related malignancies. J. Cell. Physiol. 196: 207-218, 2003. Copyright 2003 Wiley-Liss, Inc.
PMID: 12811813 [PubMed – in process]